Search results
Stat reported that Bancel led a highly secretive culture with little outside review of its science or research. Personal life. Bancel has two children. In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.
Feb 7, 2024 · Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna's board of directors since March 2011. In the 13 years since he joined Moderna, Mr. Bancel has led the company from startup to global commercial enterprise. Today, the Company has 45 mRNA therapeutic and vaccine programs in its ...
Stéphane Bancel Ingénieur transdisplinaire - Expert à la croisée des métiers et du terrain - Créateur de liens # Chef de projet Innovation / Technique # Industrie 4.0 France
- 500+
- 8.6K
Nov 16, 2020 · Stéphane Bancel is the CEO of Moderna, the company that translated the genetic code of the coronavirus into a vaccine. Moderna released results on Monday that said its vaccine is 94.5% effective...
Aug 27, 2021 · McKinsey: How can Moderna’s mRNA platform respond to new variants of coronavirus and their potential to evade the immune system? Stéphane Bancel: Some mutations of the COVID-19 virus will likely have no impact on our vaccine’s efficacy, while others might. With several mutations, there is more and more “drift” from the original SARS ...
Jun 7, 2021 · Bancel reflects on the development timeline of the vaccine: from learning about the virus while reading the Wall Street Journal in 2019 to the moment he finally got his own shot at a Moderna facility. He talks about the promise of mRNA and what’s ahead for Moderna.
Dec 12, 2021 · published 12 December 2021. If Stéphane Bancel ever questioned his ability to move markets, he got his answer last week. The Moderna CEO’s observation that existing vaccines will be less...
